DocketNumber: 12-108V
Filed Date: 2/4/2013
Status: Non-Precedential
Modified Date: 4/17/2021
In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 12-108V Filed: February 4, 2013 ______________________________________ ) STEPHANY SHAYEGHI, ) UNPUBLISHED mother and natural guardian of minor, ) AVA ROSE SHAYEGHI, ) Chief Special Master ) Campbell-Smith Petitioner, ) ) Joint Stipulation on Damages; v. ) Measles, Mumps, Rubella ) (“MMR”) Vaccine; Polio (“IPV”) SECRETARY OF HEALTH AND HUMAN ) Vaccine; Guillain-Barre SERVICES, ) Syndrome (“GBS”). ) Respondent. ) _______________________________________) Sheila Ann Bjorklund, Minneapolis, MN, for petitioner. Gordon Elliot Shemin, Washington, DC, for respondent. DECISION AWARDING DAMAGES1 On February 16, 2012, petitioner, Stephany Shayeghi, filed a petition on behalf of 1 The undersigned intends to post this decision on the website of the United States Court of Federal Claims, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, § 205,116 Stat. 2899
, 2913 (codified as amended at44 U.S.C. § 3501
note (2006)). As provided by Vaccine Rule 18(b), each party has 14 days within which to file a motion for redaction “of any information furnished by that party (1) that is trade secret or commercial or financial information and is privileged or confidential, or (2) that are medical files and similar files the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). In the absence of such motion, “the entire” decision will be available to the public.Id.
1 her minor child, Ava Rose, seeking compensation under the National Vaccine Injury Compensation Program (Athe Vaccine Program@) for a vaccine-related injury.2 On February 4, 2013, the parties in the above-captioned case filed a Stipulation memorializing their agreement as to the appropriate amount of compensation in this case. Petitioner, Stephany Shayeghi, alleged that Ava Rose suffered Guillain-Barre Syndrome (“GBS”), as a consequence of her measles, mumps and rubella (“MMR”) and polio (“IPV”) vaccinations, which vaccines are contained in the Vaccine Injury Table (the “Table”), 42 C.F.R § 100.3(a). Ms. Shayeghi further alleges that Ava Rose experienced the residual effects of this injury for more than six months and she seeks damages related to this injury pursuant to the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10 to 34. Respondent denies that Ava Rose’s alleged injury and residual effects were caused-in-fact by either the MMR or IPV vaccines. Nonetheless, the parties have agreed informally to resolve this matter. The court hereby ADOPTS the parties’ said Stipulation, attached hereto as Appendix A, and awards compensation in the amount and on the terms set forth therein. Specifically, petitioner is awarded: 1. A lump sum payment of $8109.00, representing compensation for past unreimbursable expenses, payable to Stephany Shayeghi, petitioner; 2. An amount sufficient to purchase an annuity contract, subject to the conditions described in paragraph 10 of the attached Stipulation, paid to the life insurance company from which the annuity will be purchased. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660,100 Stat. 3755
, codified as amended, 42 U.S.C.A. ' 300aa-10-' 300aa-34 (West 1991 & Supp. 2002) (Vaccine Act or the Act). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C.A. ' 300aa. 2 In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the court is directed to enter judgment herewith.3 IT IS SO ORDERED. s/Patricia E. Campbell-Smith Patricia E. Campbell-Smith Chief Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties= joint filing of notice renouncing the right to seek review. 3